शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSECCME Global Ltd· Pharmaceuticals & BiotechnologyHighNeutral
Announced Tue, 23 Dec, 2025 · 14:50 IST

Swaraj Shares and Securities Pvt Ltd ("Manager to the Offer") has submitted to BSE a copy of Post-Offer Public Announcement to the public shareholders of Genesis Ibrc India Ltd ("Target Company").

Listed-company acquisitionOpen offer triggeredStrategic Transactions View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.3%Reaction day
₹93.70
prior close
₹94.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.1%+0.3% vs market
Pharmaceuticals & Biotechnology peers, median of 160sector · industry level+0.1%+0.3% vs sector

On the reaction day the stock moved 0.3 pts more than Nifty Microcap 250 and 0.3 pts more than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
+0.0
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.3+0.1+0.3+0.1+0.3
Next day
+0.3-0.5+0.8-0.2+0.5
2d
-3.9-1.0-3.0-0.9-3.0
3d
-3.7-1.8-2.0-1.6-2.2
4d
-8.5-1.8-6.7-1.7-6.9
5d
-9.0-0.4-8.5-1.0-8.0
1w
-13.9+0.7-14.6+0.1-14.1
15d
-12.8-3.9-8.9-2.4-10.4
1m
-20.5-9.4-11.2-7.9-12.6
2m
-16.2-4.1-12.1-5.9-10.4
3m
—-16.1—-13.9—
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals & Biotechnology peers, median of 160Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Padmanaban Krishnamoorthy and Ms. V Varalakshmi (both NRIs based in Dubai) have completed an open offer for Genesis IBRC India Limited at ₹7.00 per share. The offer was for up to 26,40,039 shares (20.31% of voting capital), but only 9,00,200 shares were actually tendered and accepted, for a total consideration of ₹63,01,400. Separately, the Acquirers had already acquired 72,69,500 shares (55.92%) through an off-market transaction and 14,73,000 shares (11.33%) via a Share Purchase Agreement. Post-offer, the Acquirers hold 96,42,700 shares or 74.17% of the target company. Payment of consideration to shareholders who tendered was completed on December 23, 2025.

Likely market impact

Public shareholders who tendered will receive ₹7.00 per share. The Acquirers now control 74.17% of Genesis IBRC, leaving only 25.83% with the public — significantly reduced free float and liquidity in the stock. The Acquirers will apply to be reclassified as promoters of the company.